Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.32 |
| ▸ | RHEB | Q15382 | 1/20 | 0.32 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.31 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.31 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.31 |
| ▸ | TLR4 | O00206 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27803271 | 0.89 | NLRP3 (0.37) | LMNAALDH1A1CYP3A4HSD17B10NLRP3 | |
| SCHEMBL27803270 | 0.89 | NLRP3 (0.37) | LMNAALDH1A1CYP3A4HSD17B10NLRP3 | |
| SCHEMBL27823944 | 0.89 | NLRP3 (0.37) | LMNAALDH1A1CYP3A4HSD17B10NLRP3 | |
| SCHEMBL13954671 | 0.85 | ALDH1A1 (0.42) | CHRM1CHRM2CHRM4CHRM3ALDH1A1 | |
| SCHEMBL697497 | 0.84 | — | — | |
| SCHEMBL13954672 | 0.84 | ALDH1A1 (0.41) | CHRM1CHRM2CHRM4CHRM3ALDH1A1 | |
| SCHEMBL1594062 | 0.83 | ALDH1A1 (0.47) | LMNAALDH1A1TLR4 | |
| SCHEMBL13954661 | 0.82 | LMNA (0.34) | LMNAALDH1A1CYP3A4RHEBSLC1A3 | |
| SCHEMBL13114917 | 0.82 | LMNA (0.41) | LMNACHRM1CHRM2CHRM4CHRM3 | |
| SCHEMBL14154873 | 0.82 | LMNA (0.34) | LMNAALDH1A1CYP3A4RHEBSLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160005937-A1 | Epoxy Resin Composition and Light-Emitting Apparatus Using the Same | LG INNOTEK CO., LTD. (KR) | 2016-01-07 | — | — | US | disclosed |
| US-9096708-B2 | Partially esterified epoxy resin and epoxy resin composition applied with the same, and method for preparing the composition | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2015-08-04 | — | — | US | disclosed |
| US-20140113994-A1 | PARTIALLY ESTERIFIED EPOXY RESIN AND EPOXY RESIN COMPOSITION APPLIED WITH THE SAME, AND METHOD FOR PREPARING THE COMPOSITION | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2014-04-24 | — | — | US | disclosed |
| CN-101778820-B | Benzoyl-piperidine derivatives as dual modulators of the 5-ht2a and d3 receptors | HOFFMANN LA ROCHE | 2012-12-05 | — | — | CN | disclosed |
| CN-101778820-A | Benzoyl-piperidine derivatives as dual modulators of the 5-ht2a and d3 receptors | HOFFMANN LA ROCHE | 2010-07-14 | — | — | CN | disclosed |
| US-7740482-B2 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | BLUESTAR SILICONES FRANCE (FR) | 2010-06-22 | — | — | US | disclosed |
| US-7690783-B2 | Ink for inkjet printing, lithographic printing plate using it and method for making such plate | FUJIFILM CORPORATION (JP) | 2010-04-06 | — | — | US | disclosed |
| US-20100061212-A1 | METHOD AND DEVICE FOR OPTICAL RECORDING MEDIUM, AND OPTICAL RECORDING AND REPRODUCING APPARATUS | FUJIFILM CORPORATION (JP) | 2010-03-11 | — | — | US | disclosed |
| US-20090041945-A1 | ACTIVE RAY CURABLE COMPOSITION, POLYMERIZATION METHOD, ACTIVE RAY CURABLE INK, IMAGE FORMING METHOD, AND INK-JET RECORDING APPARATUS | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-02-12 | — | — | US | disclosed |
| US-20080180501-A1 | Actinic Ray Curable Composition, Actinic Ray Curable Ink, Image Forming Method Utilizing the Same, Ink-Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-07-31 | — | — | US | disclosed |
| US-7390840-B2 | Active ray curable composition, active ray curable ink, image forming method and inkjet recording apparatus utilizing the same | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-06-24 | — | — | US | disclosed |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-05-08 | — | — | US | disclosed |
| US-7360883-B2 | Active ray curable ink, image forming method and ink-jet recording apparatus | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-04-22 | — | — | US | disclosed |
| US-20070042275-A1 | Composition for optical recording, optical recording medium, and production method thereof | FUJI PHOTO FILM CO., LTD. | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080180501-A1 | Actinic Ray Curable Composition, Actinic Ray Curable Ink, Image Forming Method Utilizing the Same, Ink-Jet Recording Apparatus and Epoxy Compound | ROCK1, MACF1, ACTN1 | LMNA 3626/4885CHRM1 1534/4885CHRM2 3067/4885 |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | CBR3, CBR1, CNR1 | LMNA 4736/4885CHRM1 717/4885CHRM2 770/4885 |
| US-20090041945-A1 | ACTIVE RAY CURABLE COMPOSITION, POLYMERIZATION METHOD, ACTIVE RAY CURABLE INK, IMAGE FORMING METHOD, AND INK-JET RECORDING APPARATUS | RIF1, NAP1L4, NAP1L1 | LMNA 2326/4885CHRM1 1698/4885CHRM2 2698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.